Did you know? Spain is leading the way by becoming one of the first countries to introduce RSV immunisation with Nirsevimab for infants, showcasing the potential of proactive vaccination strategies. 💡 This proves that proactive vaccination policies work — but why aren’t they adopted widely? Across Europe, low vaccine budgets hinder progress, with most countries investing less than 0.5% of healthcare funds in immunisation. 📊 Discover how Spain's approach can inspire life-course immunisation across the region. Read the full report ⬇️
New report alert! 📢 We've collaborated with Bamberg Health and Asociación Española de Vacunología on a new report that highlights the need for adult vaccination strategies across Europe. Our findings underscore how life-course immunisation can reduce disease burden, lower healthcare costs, and promote economic stability. From Spain's RSV advancements to dedicated vaccine funding, this report points to critical steps for building a resilient healthcare model. Read more about our work here: 🔗 https://lnkd.in/ebfHJUit and share your thoughts on how Europe can prioritize prevention! 🌟💉 #PublicHealth #Immunisation #HealthcareInnovation #PreventiveCare #HealthyEurope
